We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Galvanize Therapeutics Electrical Pulse System Shows Promise in NSCLC Patients
Galvanize Therapeutics Electrical Pulse System Shows Promise in NSCLC Patients
November 11, 2022
Patients with non-small cell lung cancer (NSCLC) treated with Galvanize Therapeutics’ Aliya pulsed electric field (PEF) system showed more immune response than the non-treated control group, according to initial results from an ongoing trial presented at the Society for Immunotherapy of Cancer's annual meeting in Boston, Nov. 8-12.